Vaccinex VCNX
OTC VCNX
$0.69 -0.02 (-2.16%)
As of: Oct 21, 2026 · 10:31 AM EDT

Vaccinex, Inc. (VCNX) Current Deferred Revenue (2017 - 2024)

Updated

Vaccinex (VCNX) reported Current Deferred Revenue of $51,000 for Q3 2024, up 325.0% from the prior quarter.

Analysis

Vaccinex, Inc. (VCNX) Current Deferred Revenue (2017 - 2024) Analysis & Trends

At the end of FY2023, Vaccinex posted Current Deferred Revenue of $63,000.

  • Five-year quarterly Current Deferred Revenue spans a low of $12,000 in Q2 2024 and a high of $63,000 in Q4 2023.
  • Per Business Quant data, the three quarters before Q3 2024 came in at $12,000 (Q2 2024), $59,000 (Q1 2024) and $63,000 (Q4 2023).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 51,000.00
Jun 30, 2024 12,000.00
Mar 31, 2024 59,000.00
Dec 31, 2023 63,000.00
Sep 30, 2018 42,000.00
Jun 30, 2018 104,000.00
Dec 31, 2017 298,000.00
API Access

Vaccinex, Inc. Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=VCNX&period=max&api_key=YOUR_API_KEY